These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2006-003391-35 Evaluation of the efficacy and safety of unpreserved dexamethasone phosphate 0.1% eye drops (T1910) versus placebo in patients with bilateral treated severe keratoconjunctivitis sicca due to Sjögrens'... not-yet-due
Not reported 2007-002455-16 Efficacy and safety of GV 550 in acute adenoviral keratoconjunctivitis 2011-02-18 due-trials
Ongoing 2007-004473-26 Efficacy and safety of sodium cromolyn eye drops compared with placebo eye drops in patients with a history of allergic conjunctivitis using the Conjunctival Allergen Challenge model. not-yet-due
Ongoing 2007-006228-36 Efficacy and Safety Assessment of Azyter® (T1225) in Peri-Operative Antibio-Prophylaxis (ocular surface decontamination) for Cataract Surgery not-yet-due
Ongoing 2008-000580-41 Safety and Efficacy assessment of Geltim LP ® 1 mg/g (unpreserved Timolol gel – TG1030) in ocular hypertensive or glaucomatous patients stabilized by Xalatan® with ocular intolerance signs not-yet-due
Ongoing 2008-003279-28 Efficacy and safety assessment of intracameral T2380 (Fixed combination of lidocaïne, phenylephrine and tropicamide) for anaesthesia and mydriasis in phacoemulsification cataract surgery not-yet-due
Listed as ongoing, but also has a completion date 2008-003567-39 clinical efficacy and safety of azyter (azythromycin 1,5%) versus tobramycin 0,3% eye drops in the treatment of purulent bacterial conjonctivitis of children. multicenter, international, investigator-... 2011-02-28 bad-data
Ongoing 2008-004336-20 Azithromycin concentration into aqueous humor of patients undergoing cataract surgery, after 3 days of treatment by AZYTER ® not-yet-due
Listed as ongoing, but also has a completion date 2009-011157-41 Efficacy and Safety assessment of LT2345 unpreserved eye drops versus Xalatan in ocular hypertensive ou glaucomatous patients. PHase III study, international, multicentre, randomised, investigator mas... 2010-12-13 bad-data
Ongoing 2009-017388-41 Efficacy and Safety Assessment of Azyter® eye drops (T1225) in patients with blepharitis not-yet-due
Listed as ongoing, but also has a completion date 2010-021188-34 Efficacy and safety assessment of intracameral T2380 (Fixed combination of lidocaine, phenylephrine and tropicamide) for mydriasis and anaesthesia in phacoemulsification cataract surgery 2013-09-05 bad-data
Completed, but no date 2012-005576-33 Efficacy and safety assessment of intracameral T2380 (Fixed combination of lidocaïne, phenylephrine and tropicamide) to obtain mydriasis in patients with small pupils for cataract surgery by phacoemul... bad-data
Listed as ongoing, but also has a completion date 2013-001250-10 Safety and Efficacy assessment of Monoprost® (unpreserved latanoprost) in comparison with Lumigan® 0.01 % and Lumigan® 0.03% UD, in patients with open angle glaucoma or ocular hypertension, stabilized... 2016-07-28 bad-data
Listed as ongoing, but also has a completion date 2013-005222-29 Efficacy and Safety assessment of fixed combination unpreserved Latanoprost eye drops and Timolol 0.5% (T2347) versus Xalacom® in ocular hypertensive or glaucomatous patients. 2015-11-20 bad-data
Listed as ongoing, but also has a completion date 2015-005405-36 EFFICACY AND SAFETY ASSESSMENT OF T1580 VERSUS VEHICLE IN DRY EYE DISEASE TREATMENT 2019-01-08 bad-data
Ongoing 2017-000846-23 Efficacy and safety assessment of T4032 (unpreserved bimatoprost 0.01%) versus Lumigan® 0.01% in ocular hypertensive or glaucomatous patients. not-yet-due
Ongoing 2017-002823-46 Efficacy and safety assessment of T4030 eye drops (unpreserved fixed combination of bimatoprost 0.01% and timolol 0.1% or 0.5%) versus Ganfort® UD (Unit Dose) in ocular hypertensive or glaucomatous pa... not-yet-due
Ongoing 2017-003277-34 Phase IV, open-label, randomized clinical trial to evaluate the effects of Fydrane® and standard topical mydriatics and anaesthetics protocol on ocular surface after cataract surgery. not-yet-due
Ongoing 2017-003285-27 Clinical efficacy of topical hydrocortisone 0.335% (Softacort®) in patients with chronic dry eye disease and associated ocular surface inflammation not-yet-due